Pratley RE, Bauer R, Inzucchi SE, Khunti K, Kreiner EB, Laursen PN, et al
In March 2024, Wegovy was also approved to reduce the risk of major adverse cardiovascular events in those with cardiovascular disease and either overweight or obesity
Referral to endocrinology for complex cases or to registered dietitians for personalized nutrition guidance can enhance outcomes and provide additional support for patients struggling with weight management despite optimized thyroid treatment
Third, washout periods are sometimes built into protocols to distinguish acute from chronic effects
New You does not offer retatrutide but we do offer FDA-cleared, medically supervised weight-loss care today
A scoping approach was selected given the anticipated heterogeneity of study designs, the predominance of preclinical literature, and the limited volume of human clinical outcome data